[HTML][HTML] COVID-19 convalescent plasma composition and immunological effects in severe patients

Y Acosta-Ampudia, DM Monsalve, M Rojas… - Journal of …, 2021 - Elsevier
… in which, first the immunological and metabolomic status of recovered and severe patients
were evaluated. Secondly, the 28-day effect of CP on the immune response in severe patients

Clinical and immunological effects of low‐dose IFN‐α treatment in patients with corticosteroid‐resistant asthma

HU Simon, H Seelbach, R Ehmann, M Schmitz - Allergy, 2003 - Wiley Online Library
… We aimed to assess clinical and immunological effects of low-dose IFN-α in patients with
severe corticosteroid-resistant asthma with and without Churg–Strauss syndrome. There is …

[HTML][HTML] Clinical and immunological features of severe and moderate coronavirus disease 2019

G Chen, DI Wu, W Guo, Y Cao… - The Journal of …, 2020 - Am Soc Clin Investig
… of 21 patients with COVID-19 admitted to Tongji Hospital, Wuhan. We aimed to compare the
clinical and immunological features between severeseverity in the SARS-CoV-2 infection. …

Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.

C Lindholm, K Börjesson-Asp, K Zendjanchi… - The Journal of …, 2008 - jrheum.org
… Finally, 2 patients had SLE with severe mucocutaneous ulcers in the scalp and oral mucosa.
The median followup time after the anti-CD20 treatment was 22 months (range 1–61 mo). …

Immunological aspects of blood transfusions

A Brand - Transplant immunology, 2002 - Elsevier
immunological side-effects of blood transfusions are hardly available. Since the UK and
France introduced a transfusion vigilance system, severe immunological side-effects … to severe

The immunological effects of trauma

TWJ Lennard, DA Browell - Proceedings of the Nutrition Society, 1993 - cambridge.org
… The present review will examine recent findings on the immunological consequences of … to
block or augment certain immunological events. The immunological response can be seen as …

[HTML][HTML] Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study

M Vigna-Perez, B Hernández-Castro… - Arthritis research & …, 2006 - Springer
… Therefore, our data further support the therapeutic potential of Rituximab in SLE patients
with severe and refractory disease. However, it will be very important to make a further follow-up …

[HTML][HTML] Immunological predictors of disease severity in patients with COVID-19

A Al Balushi, J AlShekaili, M Al Kindi, Z Ansari… - International Journal of …, 2021 - Elsevier
… and the frequency of circulating naïve CD4 T cells can be used as independent immunological
predictors of poor outcomes in COVID-19 patients to prioritize critical care and resources. …

[HTML][HTML] Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis

Z Zhang, G Ai, L Chen, S Liu, C Gong, X Zhu… - BMC infectious …, 2021 - Springer
… We aim to explore the association of immunological features with COVID-19 severity. …
immunological features could help assess disease severity for effective triage of COVID-19 patients

[HTML][HTML] Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy

L von Bahr, B Sundberg, L Lönnies, B Sander… - Biology of Blood and …, 2012 - Elsevier
… There is concern that MSCs might further increase the risk of infections, especially in severely
immunosuppressed patients suffering from aGVHD where infection-related mortality rates …